# Effect of Vancomycin After Catheter Replacement

> **NCT04856878** · PHASE4 · UNKNOWN · sponsor: **University of Zurich** · enrollment: 100 (estimated)

## Conditions studied

- Central Line-associated Bloodstream Infection (CLABSI)
- Catheter-related Bloodstream Infection

## Interventions

- **DRUG:** Vancomycin

## Key facts

- **NCT ID:** NCT04856878
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04856878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04856878, "Effect of Vancomycin After Catheter Replacement". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04856878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*